Pre-order Enquiry
Request Free Sample
Global Hepatitis Testing Diagnosis Market Growth 2022-2028
SKU ID : LPI-20679493 | Publishing Date : 11-Apr-2022 | No. of pages : 129
As the global economy mends, the 2021 growth of Hepatitis Testing Diagnosis will have significant change from previous year. According to our researcher latest study, the global Hepatitis Testing Diagnosis market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Hepatitis Testing Diagnosis market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.
The United States Hepatitis Testing Diagnosis market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Hepatitis Testing Diagnosis market, reaching US$ million by the year 2028. As for the Europe Hepatitis Testing Diagnosis landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Hepatitis Testing Diagnosis players cover F. Hoffmann-La Roche, Abbott Laboratories, Siemens Healthineers AG, and Bio-Rad Laboratories, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Hepatitis Testing Diagnosis market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Enzyme-linked Immunosorbent Assay (ELISA)
Rapid Diagnostic Tests (RDT)
Polymerase Chain Reaction (PCR)
Isothermal Nucleic Acid Amplification Technology (INAAT)
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Blood Banks
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
F. Hoffmann-La Roche
Abbott Laboratories
Siemens Healthineers AG
Bio-Rad Laboratories
Danaher Corporation
QIAGEN
BioMerieux SA
DiaSorin S.P.A.
Ortho Clinical Diagnostics
MedMira Inc
Fujirebio
Grifols
Orasure Technologies
GenMark Diagnostics
Vela Diagnostics
Epitope Diagnostics
Trivitron Healthcare
Meril Life Sciences
geneOmbio Technologies
Molbio Diagnostics
The United States Hepatitis Testing Diagnosis market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Hepatitis Testing Diagnosis market, reaching US$ million by the year 2028. As for the Europe Hepatitis Testing Diagnosis landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Hepatitis Testing Diagnosis players cover F. Hoffmann-La Roche, Abbott Laboratories, Siemens Healthineers AG, and Bio-Rad Laboratories, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Hepatitis Testing Diagnosis market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Enzyme-linked Immunosorbent Assay (ELISA)
Rapid Diagnostic Tests (RDT)
Polymerase Chain Reaction (PCR)
Isothermal Nucleic Acid Amplification Technology (INAAT)
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Blood Banks
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
F. Hoffmann-La Roche
Abbott Laboratories
Siemens Healthineers AG
Bio-Rad Laboratories
Danaher Corporation
QIAGEN
BioMerieux SA
DiaSorin S.P.A.
Ortho Clinical Diagnostics
MedMira Inc
Fujirebio
Grifols
Orasure Technologies
GenMark Diagnostics
Vela Diagnostics
Epitope Diagnostics
Trivitron Healthcare
Meril Life Sciences
geneOmbio Technologies
Molbio Diagnostics
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Request Sample
Request Discount
